Redirecting RNA splicing by SMAD3 turns TGF-β into a tumor promoter

Mol Cell Oncol. 2016 Dec 7;4(1):e1265699. doi: 10.1080/23723556.2016.1265699. eCollection 2017.

Abstract

Transforming growth factor β (TGF-β) is a well-known growth inhibitor of normal epithelial cells, but it is also secreted by solid tumors to promote cancer progression. Our recent discovery of SMAD3-PCBP1 complex with direct RNA-binding properties has shed light on how this conversion is implemented by controlling pre-mRNA splicing patterns.

Keywords: Alternative splicing; EMT; PCBP1; SMAD3; TGF-β; metastasis.